The Association Between the Stress Hormone Cortisol and Decision-making

July 9, 2026 updated by: Marie-France Marin

Stress-induced Cortisol Clouds the Gut Feeling in Decision-making: A Randomized Controlled Study

The goal of this study is to learn how acute psychosocial stress influences decision-making in healthy young adults. It will also examine whether cortisol reactivity, a biological stress response, changes the influence of physiological emotional signals on decision-making (i.e., the gut feeling indicating risks).

The main questions it aims to answer are:

  1. Does exposure to an acute psychosocial stressor affect the development of physiological emotional signals during decision-making?
  2. Does cortisol reactivity moderate the relationship between physiological emotional signals and decision-making?
  3. Are there sex differences in these relationships?

Researchers will compare participants exposed to a standardized psychosocial stress procedure, with participants exposed to a non-stressful control condition.

Participants will:

  1. Be randomly assigned to either a psychosocial stress condition or a control condition.
  2. Complete a gambling decision-making task following the experimental manipulation.
  3. Provide multiple saliva samples and subjective stress ratings throughout the session to assess stress reactivity.
  4. Undergo continuous electrodermal activity recording during the decision-making task to measure physiological emotional signals.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

116

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H1N3M5
        • Centre de recherche de l'Institut universitaire en santé mentale de Montréal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult aged 18-35 years old.

Exclusion Criteria:

  • Current or past psychiatric/neurodevelopmental disorders
  • Physical illness
  • Medication use (except hormonal contraception)
  • Alcohol consumption exceeding Health Canada guidelines (>10 drinks/week for women, >15 for men)
  • Smoking more than 7 cigarettes/day.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stress condition
Participants completed a slightly modified version of the Trier Social Stress Task (TSST), a validated psychosocial stress induction protocol. The protocol involved a 10-minute anticipation period followed by a 10-minute test phase: a 5-minute mock job interview and a 5-minute surprise mental arithmetic task. During the test phase, participants stood in front of a one-way mirror ("Panel-out" version) and were told they were being observed by behavioral analysts and recorded via camera, although no recording took place and the analysts were lab confederates.
Participants completed a slightly modified version of the Trier Social Stress Task (TSST), a validated psychosocial stress induction protocol. The protocol involved a 10-minute anticipation period followed by a 10-minute test phase: a 5-minute mock job interview and a 5-minute surprise mental arithmetic task. During the test phase, participants stood in front of a one-way mirror ("Panel-out" version) and were told they were being observed by behavioral analysts and recorded via camera, although no recording took place and the analysts were lab confederates.
No Intervention: Control condition
In the control condition, participants read magazines for an equivalent period of time to the Stress condition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decision-making as assessed by the Iowa Gambling Task (probability of drawing from the risky decks vs safe decks)
Time Frame: Immediately after completing the experimental condition (Stress or control condition)
Decision-making was assessed using the Iowa Gambling Task. In this task, participants need to draw 100 cards among 4 decks offering different win-loss contingencies. Some card decks are risky (large gains and losses), whereas some are safe (small gains and losses). The dependent variable was a binary variable indicating whether the participant drew a card from the risky (coded as 1) or the safe decks (coded as 0).
Immediately after completing the experimental condition (Stress or control condition)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in cortisol levels between the two conditions.
Time Frame: Baseline (just before the experimental condition is conducted), 10, 20, 50, 60, 70 minutes after the beginning of the experimental condition.
Cortisol (ug/dL) was quantified for six saliva samples in each condition (Stress or control).
Baseline (just before the experimental condition is conducted), 10, 20, 50, 60, 70 minutes after the beginning of the experimental condition.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 13, 2021

Primary Completion (Actual)

November 7, 2024

Study Completion (Actual)

November 7, 2024

Study Registration Dates

First Submitted

July 1, 2026

First Submitted That Met QC Criteria

July 9, 2026

First Posted (Actual)

July 14, 2026

Study Record Updates

Last Update Posted (Actual)

July 14, 2026

Last Update Submitted That Met QC Criteria

July 9, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-2508

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The anonymized dataset used for the present study will be shared on the public repository Open Science Framework.

IPD Sharing Time Frame

Beginning at the publication of the results with no end date.

IPD Sharing Access Criteria

The IPD and supporting information will be freely accessible to the public on the OSF project associated with the study.

IPD Sharing Supporting Information Type

  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Young Adults

Clinical Trials on Trier Social Stress Test

3
Subscribe